SCHEMBL16375256

SCHEMBL16375256

C[Si](C)(CCCCCCOC(=O)NCCCCCCN=C=O)O[Si](C)(C)O[Si](C)(C)CCCCCCOC(=O)NCCCCCCOC#N

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.39
KEAP1 Q14145 3/20 0.33
NFE2L2 Q16236 3/20 0.33
EPHX2 P34913 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18386673 0.79 ACHE (0.54) ACHEKEAP1NFE2L2EPHX2
SCHEMBL23153172 0.79 ACHE (0.54) ACHEKEAP1NFE2L2EPHX2
SCHEMBL16202934 0.79
SCHEMBL19000408 0.76 ACHE (0.58) ACHEEPHX2
SCHEMBL22064745 0.76 ACHE (0.58) ACHEEPHX2
SCHEMBL28316408 0.76 ACHE (0.64) ACHEEPHX2
SCHEMBL14494732 0.76 ACHE (0.51) ACHEKEAP1NFE2L2EPHX2
SCHEMBL16351803 0.75 KEAP1 (0.36) ACHEKEAP1NFE2L2EPHX2
SCHEMBL16202936 0.75
SCHEMBL10639023 0.74 ACHE (0.61) ACHEEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004113-A1 SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS EVONIK DEGUSSA GMBH (DE) 2015-01-01 US disclosed
US-20150004112-A1 SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL EVONIK INDUSTRIES AG (DE) 2015-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004112-A1 SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL CCNI, UBE2I, CCNB1 ACHE 2875/4885KEAP1 2116/4885NFE2L2 2011/4885
US-20150004113-A1 SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS UBE2I, CCNI, IL4I1 ACHE 4294/4885KEAP1 2251/4885NFE2L2 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.